Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Scancell Holdings PLC on Thursday said its cancer vaccine had achieved early validation for clinical use. The Oxfor ...
Scancell Holdings Plc 09 January 2025 9 January 2025 Scancell Holdings plc ("Scancell" or the "Company") Scancell's Modi-1 Moditope® Vaccine Achieves Early Clinical Validation in Head and...
Scancell Holdings Plc 09 December 2024 NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND...
PLC - Oxford, England-based developer of immunotherapies - Raises GBP10.3 million from the placing and direct subscri ...
Scancell Holdings Plc 05 December 2024 NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND...
Scancell Holdings Plc 04 December 2024 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, OR INTO OR WITHIN THE UNITED STATES, AUSTRALIA, NEW...
Scancell Holdings Plc 04 December 2024 NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND...
Scancell Holdings Plc 04 December 2024 4 December 2024 Scancell Holdings plc ("Scancell" or the "Company") Scancell Announces Genmab Exercises Option to a Second Commercial License...
Scancell Holdings PLC on Monday reported positive data from an ongoing trial on patients receiving a treatment combin ...
Scancell Holdings Plc 18 November 2024 18 November 2024 Scancell Holdings plc ("Scancell" or the "Company") Scancell announces further positive data from the ongoing SCOPE trial of SCIB1...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.1 | 1.04712041885 | 9.55 | 10.25 | 9.55 | 2226238 | 9.61457445 | DE |
| 4 | -1.35 | -12.2727272727 | 11 | 11.125 | 9.2 | 1627309 | 10.08186344 | DE |
| 12 | -4.1 | -29.8181818182 | 13.75 | 17.5 | 9.2 | 1142208 | 11.85412261 | DE |
| 26 | -3.35 | -25.7692307692 | 13 | 19.5 | 9.2 | 1061790 | 13.98559474 | DE |
| 52 | -1.35 | -12.2727272727 | 11 | 19.5 | 8.86 | 758483 | 13.01984043 | DE |
| 156 | -10.6 | -52.3456790123 | 20.25 | 29.5 | 7.65 | 796795 | 14.83495133 | DE |
| 260 | 1.9 | 24.5161290323 | 7.75 | 29.5 | 4.35 | 1063650 | 15.45128465 | DE |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
